Zikai Xiong
Senior Vice President of Business Development,
zikai.xiong@immuneonco.com
Dr. Xiong brings over a decade of experience in the healthcare industry, spanning biotech and major pharmaceutical companies. At ImmuneOnco, Dr. Xiong spearheaded the 2024 out-licensing deal for VEGFxPD-L1, securing a total transaction value of USD 2 billion.
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}